Tizanidine Dosing and Safety Guidelines

Maximum Recommended Dose

• The recommended maximum daily dose of tizanidine for adults is 36 mg, divided into three 8 mg doses every 8 hours; most patients achieve optimal spasticity control with 24–36 mg per day. 1

Initiation and Titration

• Initiate therapy with 2 mg orally at bedtime, increasing by 2–4 mg every 1–7 days according to tolerability and clinical response. 1

Special Populations

Hepatic or Renal Impairment

• Tizanidine should be avoided in patients with hepatic or renal dysfunction because of heightened sedative and hypotensive effects. 1
• If use is unavoidable, dose reduction and intensive monitoring are required, although precise reduced dosing regimens are not defined. 1

Drug–Drug Interactions

• Other CYP1A2 inhibitors (e.g., oral contraceptives) markedly increase tizanidine plasma levels and adverse effects, particularly in older adults. 1
• Concurrent methadone use raises the risk of QTc interval prolongation, necessitating cardiac monitoring. 1

Adverse Effects

• The most frequently reported adverse effects at therapeutic doses include hypotension, asthenia, dizziness, and fatigue. 1
• Hepatotoxicity is a recognized risk and requires periodic liver‑function monitoring. 1

Peri‑operative and Discontinuation Considerations

• For patients treated long‑term (>9 weeks), the medication should be tapered slowly rather than stopped abruptly to prevent withdrawal symptoms. 1

Tizanidine Dosage and Administration Guidelines

Special Considerations for Older Adults

• For older adults or those with persistent pain, the American Geriatrics Society recommends starting tizanidine at 2 mg up to three times daily to minimize sedation, hypotension, and cognitive effects 2, 3
• Older persons rarely tolerate doses greater than 30-40 mg per day, and should be monitored closely for muscle weakness, urinary dysfunction, cognitive effects, sedation, and orthostasis 2

Hepatic or Renal Impairment Considerations

• The Mayo Clinic recommends avoiding tizanidine in patients with hepatic or renal dysfunction due to significant sedative and hypotensive effects 4
• Dose reduction and monitoring are recommended for both hepatic and renal impairment 5

Perioperative Management

• The Mayo Clinic recommends continuing tizanidine preoperatively, including the day of surgery, to avoid withdrawal symptoms such as rebound tachycardia, hypertension, and hypertonia 4, 2
• If discontinuation is necessary in long-term users, the Mayo Clinic recommends tapering the dose slowly 5, 4

Drug Interactions

• The Mayo Clinic warns that tizanidine is contraindicated with ciprofloxacin and fluvoxamine due to significantly reduced clearance, and may cause significant hypotension, bradycardia, and sedation with CYP1A2 inhibitors 4
• There is an increased risk of prolonged QTc when tizanidine is prescribed with methadone 5